首页> 美国卫生研究院文献>In Vivo >Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast
【2h】

Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast

机译:乳腺恶性肿瘤复发的危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background/Aim: In this study, the treatment outcome and risk factors for recurrence in patients undergoing surgery with or without adjuvant radiotherapy (RT) for malignant phyllodes tumors of the breast (MPTB) were analyzed. Patients and Methods: Forty-three patients (61.4%) underwent breast-conserving surgery (BCS) and 27 (38.6%) underwent mastectomy. Fifteen patients (21.4%) received adjuvant RT. Results: With a median follow-up of 76 months, the 7-year local control (LC), distant metastasis-free survival (DMFS), disease-free survival (DFS), and cause-specific survival (CSS) rates were 90.7%, 85.2%, 80.3%, and 87.1%, respectively. Either the extent of surgery or treatment with adjuvant RT did not affect the outcomes. On multivariate analysis, the presence of tumor necrosis was associated with inferior DFS (p=0.017), while infiltrative tumor border showed a marginal significance (p=0.078). When stratified using these two adverse pathological features, the 7-year DFS rates were 100%, 54.9%, and 55.6% in patients with 0, 1, and 2 risk factors, respectively (p=0.002). Conclusion: MPTB patients undergoing surgery with or without adjuvant RT had a favorable outcome. Although there was no local recurrence in patients treated with adjuvant RT, the effect of adjuvant RT failed to reach a statistical significance. Risk-grouping based on pathological features might help design a clinical trial for MPTB.
机译:背景/目的:在这项研究中,分析了接受或不接受辅助放疗(RT)的乳腺癌恶性叶状瘤(MPTB)手术患者的治疗结果和复发风险因素。患者和方法:43例(61.4%)接受了保乳手术(BCS),27例(38.6%)进行了乳房切除术。 15名患者(21.4%)接受了辅助放疗。结果:中位随访76个月,7年局部对照(LC),远处无转移生存(DMFS),无病生存(DFS)和因因生存(CSS)的比率为90.7分别为%,85.2%,80.3%和87.1%。手术或辅助放疗的治疗程度均不影响预后。在多变量分析中,肿瘤坏死的存在与DFS较差相关(p = 0.017),而浸润性肿瘤边界则显示出边缘意义(p = 0.078)。当使用这两种不良病理特征进行分层时,具有0、1、2危险因素的患者的7年DFS发生率分别为100%,54.9%和55.6%(p = 0.002)。结论:接受或不接受辅助放疗的MPTB患者均获得良好的治疗效果。尽管接受辅助放疗的患者没有局部复发,但是辅助放疗的效果未能达到统计学意义。基于病理特征的风险分组可能有助于设计MPTB的临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号